| Literature DB >> 8926043 |
K E Foreman1, M M Glovsky, R L Warner, S J Horvath, P A Ward.
Abstract
Complement activation is known to enhance neutrophil binding to human umbilical vein endothelial cells (HUVECs). Recently, we have shown that recombinant human C5a upregulates P-selectin in HUVECs. Unstimulated human neutrophil binding is also increased on C5a stimulated HUVECs. We demonstrate in this report that C5a upregulates CD11b/CD18 in human neutrophils. Also shown is that synthetic C3a57-77 and an analog 15 amino acid C3a peptide (C3a15) neither upregulate CD11b/CD18 nor do the C3a peptides increase P-selectin, ICAM-1 or E-selectin in HUVECs. Thus C5a and not C3a is responsible for early (approximately 30 minutes) neutrophil adhesion to endothelial cells after complement activation.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8926043 DOI: 10.1007/bf01487740
Source DB: PubMed Journal: Inflammation ISSN: 0360-3997 Impact factor: 4.092